CRISTINA
BENITO VILLALVILLA
Profesora ayudante
Novartis (Sweden)
Täby, SueciaPublicaciones en colaboración con investigadores/as de Novartis (Sweden) (2)
2023
-
Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 4, pp. 1060-1072
2021
-
Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs
European Respiratory Journal